Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
शेयरों में रैंक #178
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
शेयर मूल्य
$44.60
मार्केट कैप
$108.62B
बदलाव (1 दिन)
-1.63%
बदलाव (1 वर्ष)
-21.62%
देश
FR
व्यापार Sanofi (SNY)

श्रेणी

Sanofi (SNY) के लिए राजस्व
Dec 2025 में राजस्व TTM: $54.81B
Sanofi की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान राजस्व (TTM) $54.81B है। 2024 में, कंपनी ने $46.08B का राजस्व अर्जित किया जो 2023 के $46.01B के राजस्व से की वृद्धि है। राजस्व वह कुल आय है जो कंपनी अपने उत्पादों या सेवाओं की बिक्री से उत्पन्न करती है। लाभ की तुलना में इसमें कोई खर्च घटाया नहीं जाता।
Sanofi के लिए 2000 से 2026 तक की राजस्व इतिहास
प्रत्येक वर्ष के अंत में राजस्व
वर्ष राजस्व परिवर्तन
2026 (TTM) $54.81B 0.00%
2025 $54.81B 18.94%
2024 $46.08B 0.16%
2023 $46.01B 5.74%
2022 $43.51B -2.33%
2021 $44.55B -2.12%
2020 $45.51B 7.79%
2019 $42.22B 2.98%
2018 $41.00B -5.67%
2017 $43.46B 19.05%
2016 $36.51B -3.56%
2015 $37.85B -2.23%
2014 $38.72B -10.02%
2013 $43.03B -9.28%
2012 $47.43B 4.51%
2011 $45.38B -0.27%
2010 $45.51B 3.21%
2009 $44.09B 9.79%
2008 $40.16B -5.93%
2007 $42.69B 10.03%
2006 $38.80B 15.26%
2005 $33.66B 57.92%
2004 $21.32B 110.71%
2003 $10.12B 29.32%
2002 $7.82B 35.65%
2001 $5.77B 3.32%
2000 $5.58B 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए राजस्व
कंपनी राजस्व राजस्व में अंतर देश
$65.18B 18.92%
US
$58.74B 7.17%
GB
$94.19B 71.85%
US
$61.16B 11.58%
US
$56.15B 2.44%
CH